Top brokers name 3 ASX shares to buy next week

Brokers are feeling bullish on these ASX shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last week saw a number of broker notes hitting the wires once again. Three buy ratings that investors might want to be aware of are summarised below.

Here's why brokers think investors ought to buy them next week:

Broker written in white with a man drawing a yellow underline.

Image source: Getty Images

Allkem Ltd (ASX: AKE)

According to a note out of Morgans, its analysts have upgraded this lithium miner's shares to an add rating with an improved price target of $15.70. The broker highlights that concerns over lithium demand in China weighed heavily on lithium shares last week. This is despite spot prices remaining largely unchanged. The broker sees this as a buying opportunity and suspects its shares could rebound strongly if spot prices remain steady into the new year. The Allkem share price ended the week at $14.00.

Aristocrat Leisure Limited (ASX: ALL)

Another note out of Morgans reveals that its analysts have retained their buy rating and $43.00 price target on this gaming technology company's shares. Morgans notes that Aristocrat's shares tumbled into the red last week following the release of its FY 2022 results. The broker believes this has also created a buying opportunity. Particularly given its belief that Aristocrat will deliver NPATA growth of 14.7% in FY 2023 and 7.9% in FY 2024. The Aristocrat share price was fetching $36.20 at Friday's close.

Breville Group Ltd (ASX: BRG)

Analysts at Goldman Sachs have retained their buy rating on this appliance manufacturer's shares with a trimmed price target of $23.40. According to the note, Breville's first half performance so far has been a touch softer than it was expecting. However, thanks partly to its strong position in the at-home coffee market, the broker continues to forecast double digit earnings growth through to FY 2025. The Breville share price ended the week at $20.31.

Motley Fool contributor James Mickleboro has positions in Allkem Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

Macquarie shares: Buy, hold or sell?

Two top analysts offer their outlook for Macquarie’s outperforming shares.

Read more »

A steel worker peers out from under his protective headwear which is tipped back on his head as he stares solemnly straight ahead with steel production equipment in the background.
Broker Notes

Bell Potter says this beaten-down ASX materials stock can rise 56%

Down 17% this year, Bell Potter says ASX materials stock has significant upside.

Read more »

A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
Broker Notes

This ASX small-cap is tipped to almost double in the next year

Bell Potter just raised its guidance on this ASX small-cap.

Read more »

Man sits smiling at a computer showing graphs.
Broker Notes

6 ASX 200 shares with strengthened buy ratings this week

Brokers have maintained confidence in these ASX 200 stocks amid today's volatile market conditions.

Read more »

A happy person clenching fists in celebration sitting at computer.
Broker Notes

Morgans says hold BHP shares and buy this ASX 200 stock      

Let's see what the broker is saying about these stocks this week.

Read more »

An ASX 200 market analyst holds his hand to his chin and looks closely at his computer screens watching share price movements
Broker Notes

3 ASX 200 shares just upgraded to strong buy — here's what the brokers are saying

Do any of these ASX 200 stocks appeal to you?

Read more »

Person pressing the buy button on a smartphone.
Broker Notes

3 reasons to buy Pro Medicus shares today

A leading analyst believes Pro Medicus shares are now trading at a significant discount.

Read more »

Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Macquarie, Santos shares

Brokers reveal their latest ratings and reviews on 3 ASX 200 stocks.

Read more »